Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin

Fig. 1

Clinical relevance of ANP32E in pancreatic cancer patients. a The transcript abundance of ANP32E in PAAD (n = 179, red box) and normal tissues (n = 175, gray box) was analyzed from TCGA database. p < 0.001. b PAAD patients were divided into ANP32E high expression (n = 89, green line) and low expression (n = 89, yellow line) group. Overall survival for ANP32E was analyzed. p = 0.049. c PAAD patients were divided into ANP32E high expression (n = 45, red line) and low expression (n = 45, blue line) group. Disease free survival for ANP32E was analyzed. p = 0.045. d qRT-PCR and Western blot analysis of ANP32E in human normal ductal epithelial cells of the pancreas HPDE and pancreatic cancer cells AsPC1, PANC1 and MIA. *p < 0.05. **p < 0.01. Full-length gels are presented in Supplementary Figure 2

Back to article page
\